A primary goal of the Coordinating Center is promotion of information access, information exchange, interaction, and collaboration among members of the SCLC Consortium. To these ends, the Coordinating Center provides administrative oversight for the group of investigators researching SCLC, including coordination of regular teleconferences and assistance in planning an annual face-to-face meeting. These activities will promote the coherence of the group, and stimulate collaboration among the investigators.
External advisory board
We have established an external advisory board of senior investigators with complementary expertise in SCLC to provide strategic advice to the Center. We believe the external advisory board can increase the flexibility and responsiveness of the Center by helping to identify opportunities and suggesting redirection of funds within the Center to address new and emerging areas of interest. The EAB includes Paul Bunn, Caroline Dive, Bruce Johnson, and Pierre Massion. The group offers complementary strengths in drug development, animal modeling, molecular targets, and early detection.
Administrative oversight and communications
We hold monthly WebEx teleconferences among the participating members of the consortium to review progress and opportunities among the group. This in part serves as a forum for updates regarding databases and other shared resources and opportunities of relevance to the whole group. In addition, as the primary focus of these calls, we have a rotating schedule of presentation, with one research laboratory assigned to present on each teleconference.
The Consortium will have annual face-to-face meetings, alterating between smaller focused meetings at or around NCI for funded investigators, and a larger international meeting which we have held with the support and engagement of the International Association for the Study of Lung Cancer (IASLC).
The Coordinating Center has developed and maintained this website for the SCLC Consortium.